Purchase Order HT940626PE007
- Not listed
- The Defense Health Agency awarded a firm fixed-price purchase order to Fenwal, Inc. on March 25, 2025, for the supply of intravenous fluids for blood bank operations. Valued at $16,608.88 with an ultimate completion date of September 1, 2025, this contract represents a non-set-aside award supporting critical blood banking capabilities. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, will perform this work at Agana...
- The U.S. Defense Department's Medical Supply Chain, through its Defense Logistics Agency, awarded a $1,148.65 firm fixed-price purchase order to Fenwal, Inc. for blood collection assemblies. The contract, issued on September 16, 2025, with an ultimate completion date of September 22, 2025, carries no set-aside designation and represents a competitive award to the prime contractor. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich,...
- The U.S. Defense Department's Medical Supply Chain awarded a $30,835.84 firm fixed-price purchase order to Fenwal, Inc. for blood packs with anticoagulant on May 20, 2025, with a completion deadline of July 21, 2025. The contract, which carries no set-aside designation, will be performed at Fenwal's manufacturing facility in Lake Zurich, Illinois. Fenwal, Inc. is a subsidiary of Fresenius Kabi and operates as a specialized supplier of blood collection, processing, storage, and transfusion...
- This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Fenwal, Inc., a Fresenius Kabi company, for the supply of specialized blood collection, separation, storage, and transfusion products and services. The $1,176.75 contract will support the U.S. military's frozen blood program and provide consumables, cell processing kits, separators, and service agreements to facilitate biomedical research and blood banking operations for the federal government. Fenwal, a...
- This $1,839.04 firm-fixed-price purchase order was awarded by the Defense Logistics Agency Troop Support Medical, a component of the U.S. Department of Defense, to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of 8510030904 - BLOOD PACK WITH ANT, a medical supply item used in transfusion medicine and cell therapy applications. Fenwal, a registered government vendor since 2007, has a history of providing a diverse array of...
- This firm-fixed-price purchase order contract was awarded by the Defense Health Agency to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $846,759.26 contract is for the delivery of blood collection bags and has a completion date of November 30, 2025. Fenwal, Inc. is a foreign-owned, for-profit manufacturer specializing in blood collection, separation, storage, and transfusion products and services. The company has a strong track record of providing critical...
- The Department of Veterans Affairs awarded a $391,423.95 firm fixed price purchase order to Fenwal, Inc. to supply specialized blood bags and blood glucose solution for the military's frozen blood program. The contract was awarded on a sole source basis after market research found Fenwal to be the only provider of the required Glycerolyte 57% glass bottles containing 100ml each and Military Quad blood bags containing 450ml each. These products have been developed specifically for the...
- The Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price purchase order to Fenwal, Inc. for blood packs with anticoagulant, with a ceiling value of $3,462. The award, issued on July 31, 2018, with an ultimate completion date of August 6, 2018, represents a routine consumable procurement for military medical supply operations. No set-aside designation was used for this acquisition, reflecting Fenwal's established position as a qualified supplier of specialized blood products...
- This is a $21,400 firm-fixed-price purchase order awarded to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, by the Defense Health Agency. The contract is for the supply of various medical supplies and equipment to support transfusion medicine and cell therapy applications, including blood bags, tubing, solutions, apheresis equipment, and other specialized items used in blood banking and biomedical research operations. The award does not have a set-aside...
- The U.S. Department of Veterans Affairs (VA) has awarded a firm-fixed-price contract worth $645,972.48 to Fenwal, Inc., a subsidiary of Fresenius Kabi, to provide military blood bags and accessories for the Capt. James A. Lovell Federal Healthcare Center in North Chicago, Illinois. This sole-source contract, awarded under FAR 6.302-1, includes the supply of glycerolyte solution, sodium chloride solution, blood bag containers, and other specialized blood collection and processing products....
The Defense Health Agency awarded a firm fixed-price purchase order to Fenwal, Inc. on December 1, 2025, for the supply of frozen blood, blood collection bags, and glycerolyte 57% solutions. The contract, valued at $237,718.20 with an ultimate completion date of September 30, 2026, will be performed at Camp Lejeune, North Carolina. This award carries no set-aside designation, reflecting Fenwal's specialized capabilities as the sole source provider for these critical blood banking consumables and solutions. As a subsidiary of Fresenius Kabi and a global leader in transfusion medicine technology, Fenwal has been a continuous federal vendor since 2007, serving multiple Department of Defense and federal health agencies through its extensive portfolio of blood collection, storage, and transfusion products. Fenwal's supply of blood collection bags and glycerolizing solutions supports the Defense Health Agency's mission to provide medical readiness and healthcare services across the military health system. These consumables are essential components of blood banking operations, enabling the collection, preservation, and storage of blood products for military medical facilities. The contract demonstrates the Defense Health Agency's reliance on specialized commercial vendors to maintain critical supplies for military blood banks, which are vital to sustaining medical readiness and trauma care capabilities at military treatment facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $237.7k | 11/30/25 |